PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Acerta Pharma BV
Center for International Blood and Marrow Transplant Research
City of Hope Medical Center
M.D. Anderson Cancer Center